Clinical trial
Lot-to-Lot Consistency Study of the Investigational, Inactivated, Split-Virion…
NCT00383539 · Sanofi Pasteur, a Sanofi Company, Industry · Completed
Key facts
| NCT number | NCT00383539 |
|---|---|
| Title | Lot-to-Lot Consistency Study of the Investigational, Inactivated, Split-Virion Influenza Vaccine in Adults |
| Lead sponsor | Sanofi Pasteur, a Sanofi Company, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Orthomyxoviridae Infection, Influenza, Myxovirus Infection |
| Intervention type | Biological |
| Interventions | Inactivated Split-virion influenza vaccine |
| Enrollment | 2,256 |
| Start date | Sep 1, 2006 |
| Primary completion | Jul 1, 2007 |
| Completion | Dec 1, 2007 |
| First posted | Oct 3, 2006 |
| Last update posted | Jan 14, 2014 |
| Countries | France, Lithuania, Spain, United Kingdom |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: